News|Videos|July 10, 2025
Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity
Author(s)Christopher Cole
Advertisement
In this quick clip from our BIO 2025 interview with Junevity Co-founder and CEO John Hoekman, PhD, Dr. Hoekman summarizes the potential of siRNA to fight diseases like diabetes and obesity.
Check out the full interview
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Applying Analytical Quality by Design Principles to Biopharma Method Development and Optimization
2
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Why Radiopharmaceuticals Are Ideal for Treating Cancer
5
